Camp4 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	208	105	-	-
Enterprise Value	139	274	-	-
Last Close Price	4.01	5.22	-	-
PS Ratio	54.72	161.17	-	-
PB Ratio	3.20	1.66	-	-
P/TBV Ratio	3.55	1.66	-	-
EV/Sales Ratio	36.60	420.77	-	-
Debt / Equity Ratio	0.11	0.14	0.32	0.15
Net Debt / Equity Ratio	-1.17	-0.88	-0.68	-0.84
Net Debt / EBITDA Ratio	1.34	1.08	0.52	1.60
Net Debt / FCF Ratio	1.45	1.20	0.58	1.66
Asset Turnover	0.07	0.01	0.00	-
Quick Ratio	9.52	6.68	4.97	10.56
Current Ratio	9.83	6.92	5.13	10.62
Return on Equity (ROE)	-172.70%	-101.99%	-80.13%	-
Return on Assets (ROA)	-61.85%	-49.80%	-41.17%	-
Return on Capital Employed (ROCE)	-67.90%	-77.30%	-110.10%	-47.60%
Earnings Yield	-25.67%	-49.29%	-	-
FCF Yield	-22.92%	-43.78%	-	-
Buyback Yield / Dilution	-4278.53%	-1087.44%	-26.47%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q